Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - Results from a randomized trial

European Journal of Internal Medicine

Volumn 24, Issue 7, 2013, Pages 644-649

  Wamberg, L ^a,b   Kampmann, U ^a,b   Stodkilde Jorgensen H ^a,b   Rejnmark, L ^b   Pedersen, S B ^b   Richelsen, B ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Abdominal obesity; Body fat distribution; Inflammation; Insulin resistance; Magnetic resonance imaging; Vitamin D

Indexed keywords

COLECALCIFEROL; LIPID; PARATHYROID HORMONE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; BODY FAT; CARDIOMETABOLIC RISK; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERCALCEMIA; INSULIN RESISTANCE; INTRAABDOMINAL FAT; LIPID BLOOD LEVEL; LIPID STORAGE; NAUSEA; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OBESITY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SUBCUTANEOUS FAT; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ABDOMINAL OBESITY; BODY FAT DISTRIBUTION; INFLAMMATION; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; VITAMIN D;

ADIPOSE TISSUE; ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; METABOLIC DISEASES; MIDDLE AGED; OBESITY; PLACEBOS; RISK FACTORS; TREATMENT OUTCOME; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS; YOUNG ADULT;

EID: 84884280021     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2013.03.005     Document Type: Article

References (39)

1. C.S. Fox, J.M. Massaro, and U. Hoffmann Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study Circulation 116 2007 39 48
2. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
3. D.B. Savage, K.F. Petersen, and G.I. Shulman Disordered lipid metabolism and the pathogenesis of insulin resistance Physiol Rev 87 2007 507 520
4. C.P. Earthman, L.M. Beckman, K. Masodkar, and S.D. Sibley The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications Int J Obes 36 2012 387 396
5. M. Caron-Jobin, A.-S. Morisset, A. Tremblay, C. Huot, D. Legare, and A. Tchernof Elevated serum 25(OH)D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women Obesity 19 2011 1335 1341
6. S. Cheng, J.M. Massaro, and C.S. Fox Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study Diabetes 59 2010 242 248
7. R. Kremer, P.P. Campbell, T. Reinhardt, and V. Gilsanz Vitamin D status and its relationship to body fat, final height, and peak bone mass in young women J Clin Endocrinol Metab 94 2009 67 73
8. Y. Kamei, T. Kawada, R. Kazuki, T. Ono, S. Kato, and E. Sugimoto Vitamin-D receptor gene-expression is up-regulated by 1, 25-dihydroxyvitamin-D3 in 3t3-L1 preadipocytes Biochem Biophys Res Commun 193 1993 948 955
9. X.M. Mai, Y. Chen, C.A. Camargo Jr., and A. Langhammer Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study Am J Epidemiol 175 2012 1029 1036
10. C. Mattila, P. Knekt, and S. Mannisto Serum 25-hydroxyvitamin D concentration and subsequent risk of type 2 diabetes Diabetes Care 30 2007 2569 2570
11. C. Gagnon, Z.X. Lu, and D.J. Magliano Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab) J Clin Endocrinol Metab 97 2012 1953 1961
12. J.P. Forman, G.C. Curhan, and E.N. Taylor Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women Hypertension 52 2008 828 832
13. A. Zittermann, S. Frisch, and H.K. Berthold Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers Am J Clin Nutr 89 2009 1321 1327
14. J. Nagpal, J.N. Pande, and A. Bhartia A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men Diabet Med 26 2009 19 27
15. P.R. von Hurst, W. Stonehouse, and J. Coad Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial Br J Nutr 103 2010 549 555
16. L. Lind, B. Wengle, and S. Ljunghall Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study Acta Med Scand 222 1987 423 427
17. M. Pfeifer, B. Begerow, H.W. Minne, D. Nachtigall, and C. Hansen Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women J Clin Endocrinol Metab 86 2001 1633 1637
18. R. Jorde, and Y. Figenschau Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels Eur J Nutr 48 2009 349 354
19. J.L. Rosenblum, V.M. Castro, C.E. Moore, and L.M. Kaplan Calcium and vitamin D supplementation is associated with decreased abdominal visceral adipose tissue in overweight and obese adults Am J Clin Nutr 95 2012 101 108
20. V. Positano, A. Gastaldelli, A.M. Sironi, M.F. Santarelli, M. Lombardi, and L. Landini An accurate and robust method for unsupervised assessment of abdominal fat by MRI J Magn Reson Imaging 20 2004 684 689
21. M. Maersk, A. Belza, and H. Stodkilde-Jorgensen Sucrose-sweetened beverages increase fat storage in the liver, muscle, and visceral fat depot: a 6-mo randomized intervention study Am J Clin Nutr 95 2012 283 289
22. S.W. Provencher Estimation of metabolite concentrations from localized in vivo proton NMR spectra Magn Reson Med 30 1993 672 679
23. Z. Maunsell, D.J. Wright, and S.J. Rainbow Routine isotope-dilution liquid chromatography-tandem mass spectrometry assay for simultaneous measurement of the 25-hydroxy metabolites of vitamins D2 and D3 Clin Chem 51 2005 1683 1690
24. C.S. Hojskov, L. Heickendorff, and H.J. Moller High-throughput liquid-liquid extraction and LCMSMS assay for determination of circulating 25(OH) vitamin D3 and D2 in the routine clinical laboratory Clin Chim Acta 411 2010 114 116
25. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
26. I. Abraha, and A. Montedori Modified intention to treat reporting in randomised controlled trials: systematic review BMJ 340 2010 c2697
27. R.M. Daly, and C.A. Nowson Long-term effect of calcium-vitamin D(3) fortified milk on blood pressure and serum lipid concentrations in healthy older men Eur J Clin Nutr 63 2009 993 1000
28. R. Jorde, M. Sneve, P. Torjesen, and Y. Figenschau No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year J Intern Med 267 2010 462 472
29. M.P. Ponda, X. Huang, M.A. Odeh, J.L. Breslow, and H.W. Kaufman Vitamin D may not improve lipid levels: a serial clinical laboratory data study Circulation 126 2012 270 277
30. R. Jorde, M. Sneve, P.A. Torjesen, Y. Figenschau, L.G. Goransson, and R. Omdal No effect of supplementation with cholecalciferol on cytokines and markers of inflammation in overweight and obese subjects Cytokine 50 2010 175 180
31. A.G. Pittas, S.S. Harris, P.C. Stark, and B. Dawson-Hughes The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults Diabetes Care 30 2007 980 986
32. K. Tai, A.G. Need, M. Horowitz, and I.M. Chapman Glucose tolerance and vitamin D: effects of treating vitamin D deficiency Nutrition 24 2008 950 956
33. J.M. Blumberg, I. Tzameli, I. Astapova, F.S. Lam, J.S. Flier, and A.N. Hollenberg Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells J Biol Chem 281 2006 11205 11213
34. C.J. Narvaez, D. Matthews, E. Broun, M. Chan, and J. Welsh Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue Endocrinology 150 2009 651 661
35. C. Ding, D. Gao, J. Wilding, P. Trayhurn, and C. Bing Vitamin D signalling in adipose tissue Br J Nutr 2012 1 9
36. L.S. Szczepaniak, E.E. Babcock, and F. Schick Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo Am J Physiol 276 1999 E977 E989
37. L.S. Bhatia, N.P. Curzen, P.C. Calder, and C.D. Byrne Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor? Eur Heart J 33 2012 1190 1200
38. G. Targher, L. Bertolini, and L. Scala Associations between serum 25-hydroxyvitamin D3 concentrations and liver histology in patients with non-alcoholic fatty liver disease Nut Metab Cardiovasc Dis 17 2007 517 524
39. C.L. Roth, C.T. Elfers, and D.P. Figlewicz Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation Hepatology 55 2012 1103 1111